Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
39.34
50.85
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Yunnan Botanee Bio-Technology Group Co Ltd
Total Liabilities & Equity
Yunnan Botanee Bio-Technology Group Co Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Total Liabilities & Equity
ÂĄ8.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Total Liabilities & Equity
ÂĄ42.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
2%
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Total Liabilities & Equity
ÂĄ8.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
Total Liabilities & Equity
ÂĄ14.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
18%
|
|
|
S
|
Shanghai Chicmax Cosmetic Co Ltd
HKEX:2145
|
Total Liabilities & Equity
ÂĄ3.6B
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Total Liabilities & Equity
ÂĄ8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
Glance View
In the lush landscape of China's Yunnan province, Yunnan Botanee Bio-Technology Group Co Ltd has emerged as a formidable player in the skincare and beauty industry. This company, with its roots deeply intertwined with the rich biodiversity of the region, focuses on harnessing the natural bounty of botanicals to develop innovative skincare solutions. Their expertise lies in transforming these local plant resources into high-value products, capitalizing on the growing global demand for natural and organic ingredients. Each product is a testament to the company's commitment to sustainability and scientific innovation, appealing to a modern consumer base increasingly conscious about the origins and effectiveness of their skincare products. The company’s business model effectively capitalizes on both upstream and downstream processes in the beauty value chain. By controlling the entire journey from plant cultivation to product formulation and final marketing, Yunnan Botanee ensures quality and authenticity at every stage. Their flagship brand, Winona, has carved out a niche in the sensitive skin category, leveraging cutting-edge dermatological research and traditional Chinese herbal knowledge. This strategic positioning, along with strong direct-to-consumer sales combined with an omnichannel retail strategy, bolsters its revenue streams and enhances brand loyalty. Through this integrated approach, the company not only rides the wave of clean beauty trends but also sets a benchmark for sustainable growth in the industry.
See Also
What is Yunnan Botanee Bio-Technology Group Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
8.3B
CNY
Based on the financial report for Dec 31, 2024, Yunnan Botanee Bio-Technology Group Co Ltd's Total Liabilities & Equity amounts to 8.3B CNY.
What is Yunnan Botanee Bio-Technology Group Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
50%
Over the last year, the Total Liabilities & Equity growth was 11%. The average annual Total Liabilities & Equity growth rates for Yunnan Botanee Bio-Technology Group Co Ltd have been 13% over the past three years , 50% over the past five years .